Certified B Corps are companies that meet exceptionally high standards of social and environmental performance, transparency and accountability.
The process examines a company’s full range of processes, from supply chain to charitable giving and employee benefits.
Other well-known names that have achieved B Corp status include Patagonia, The Body Shop, BrewDog, TOMS, Ben and Jerry’s and Innocent Drinks.
Dr Caroline Collins, from Pennard Vets, said: “We’re extremely proud to achieve B Corp status and there’s no doubt that it will be transformational for the business, in the same way that becoming an employment ownership trust has been.
"Being employee owned and socially minded is a huge draw for vets and nurses seeking a change in their career, who want to be part of an organisation where they can have a real say in the running of the practice and make a tangible difference to the environment.
“It also means that we can now make very long-term decisions, that could even take several decades to pay off, which would be very difficult to do in a traditional shareholder business, and that gives our team the authority to always do the right thing.”
Animalcare has announced the launch of Identichip Ultra, a new slimline microchip with enhanced read range for smaller species
The new microchip is 1.4mm wide and is inserted with a 15 gauge needle which is 50% slimmer than the needle used with standard microchips. The length of the mini microchip has been increased to 10.3mm to accommodate a longer ferrite rod which boosts the signal to the microchip scanner.
Animalcare says Identichip Ultra has been designed to offer a slimline microchipping solution for small species and breeds with a reduced compromise on read range.
Beverley Campbell, Identichip and Anibase Product Manager said: “We recognised the increasing trend for slimmer microchips and the benefit this offers for small species and breeds. We also know that mini microchips have a reduced read range which could ultimately lead to a microchip not being detected so we wanted to challenge this and bring a solution to the market.
"Identichip Ultra is as slim as the other mini microchips currently being offered but the increased length gives us a read range up to 24% further1. We firmly believe that there is a place for mini microchips in the market and while we have enhanced the read range versus other mini brands we still believe that standard size microchips should be used in larger animals. We would encourage implanters to always choose a microchip size suitable for that particular animal in relation to its size now and when fully grown.”
With compulsory microchipping of dogs due to be introduced in England, Scotland and Wales from April 2016 awareness of microchipping is increasing. However, Animalcare says it still feels there is a lot of education needed to ensure dog owners are prepared for the legislation. For this reason, it has produced a range of promotional materials including leaflets, posters, letter templates and digital stickers.
Identichip Ultra is available in a sterile packed syringe style implanter with a detachable needle for sharps disposal.
For further information speak to your Animalcare Representative.
1Based on a laboratory trial comparing mini microchips (1.4mm x 8.5mm), standard microchips (2.1mm x 12.5mm) and idENTICHIP Ultra (1.4mm x 10.3mm) using three different microchips scanners (RT100-V5, Halo Scanner and idENTICHIP Pocket Reader)
The College wants more vets to come and share their ideas and insights into how the role of the veterinary nurse can be strengthened within the team, particularly in the light of data gathered from the RCVS’s 2024 VN Vision workshops which showed that many nurses believe their skills and capabilities, and the scope of tasks that can be performed within the current legal framework, are not fully used.
The first two events, in South Wales and Belfast, were well-attended by veterinary nurses, but only about 10% of attendees were vets who arguably have the most to gain by sharing ways of enabling nurses to perform a more central role and relieve some of their workload.
There are four more events coming up:
RCVS Director of Veterinary Nursing, Julie Dugmore, said: “Last year’s VN Vision events focused specifically on veterinary nurses and resulted in some truly inspiring insights. Now, in this new series of events, we’re taking the next step, and need to get the wider practice team involved in order to understand how strengthening the VN role will feed into team dynamics and the professions as a whole.
“Our latest VN Vision events will play a key role in helping us to define long term goals, identify the practical steps needed to achieve them, and determine how success will be measured and shared with the wider public. To make it happen, we need voices from vets, practice managers, support staff, and VNs alike.”
The VN Vision workshops are free to attend, informal, informative and made up of small groups.
Supper will also be provided for the evening sessions, and lunch for the London day workshops.
https://www.eventbrite.com/cc/vet-nursing-vision-events-3253639
From 1st March vets can sign up to be alerted to all recorded equine influenza cases in the UK, thanks to a new service from the Animal Health Trust (AHT) and Merial Animal Health.
Tell Tail is the UK's first equine influenza (EI) text alert service exclusively for equine vets, set up to provide practices and their clients with what could be invaluable information in the face of a potential outbreak.
Dr Emma Batson from Merial said: "Vets will be notified of an EI outbreak within 48 hours of confirmed diagnosis. Not only will this allow them to alert their clients, but we believe that it will also help to encourage horse owners to become more compliant with vaccination schedules.
"Currently it is estimated that only a third of the UK horse population is vaccinated for EI. This situation is not only a potential welfare issue, but it also provides practices with a significant opportunity to increase the number of horses protected against EI, resulting in a win-win situation for all."
Dr Richard Newton, Head of Epidemiology and Disease Surveillance at the AHT, believes the text alert service will also help improve awareness and knowledge of EI, and he hopes all equine vets will sign up for the scheme. He said: "We believe that the launch of the alert service for vets marks an important step in the quest to help minimise the risk of an EI outbreak in the UK.
"EI doesn't have a carrier state, which means that it never goes away and re-emerges, instead it circulates continuously. So without continued surveillance we could easily lose track of it.
"We hope that as well as allowing practices to track and respond to outbreaks in their area, the alerts will also encourage vets to send in samples from animals with cold and flu-like symptoms. This is a free service which in turn provides us with more information to circulate within the industry, allowing everyone to be more effective at managing the disease.
"Vaccination is our best defence against EI, but to remain effective the World Organisation for Animal Health (OIE) Expert Surveillance Panel, needs to make any update recommendations based on the latest position in the field. And this information can only be gathered via effective surveillance."
Dr Batson agrees and hopes that the combination of the Tell Tail text alert service and surveillance scheme will help to reduce the risk of an outbreak occurring in the UK. She said: "In the UK we continue to see regular confirmed outbreaks of EI, so we can never afford to become complacent about the risks.
"You only have to look at the relatively recent major outbreaks in Australia, South Africa, India and China, to see the devastating effects which can ripple throughout equine industries, both in financial as well as welfare terms."
Tell Tail is a free service. To register your interest, text your name, practice and postcode to 07797 801863. Alternatively, visit http://www.merial.com/ and click on the Tell Tail link, or speak to your Merial territory manager.
The RCVS Disciplinary Committee has reprimanded and warned as to his future conduct a Hampshire veterinary surgeon found guilty of serious professional misconduct for cumulative failures to provide adequate professional care, and insufficient regard for animal welfare whilst treating a dog that had ingested broken glass.
The sanction was decided following a 12-month postponement of a decision ordered at a hearing on 19 November 2010.
At last week's hearing, the Committee was asked to decide what sanction would be appropriate in the case of Peter Ardle MacMahon for his treatment of a Cocker Spaniel called Wilfred, while working as a locum in Portsmouth. In 2010, the Committee found that Mr MacMahon had not removed the ingested glass from Wilfred's stomach or adequately checked that he had done so; had inadequately prevented abdominal contamination; and, had failed to communicate this contamination problem to Wilfred's usual veterinary surgeon. Considering these charges cumulatively, the Committee found that the treatment Mr MacMahon provided to Wilfred had fallen far short of the standard to be expected in the profession and amounted to serious professional misconduct.
Shortly prior to treating Wilfred, Mr MacMahon had returned to practice after a ten-year absence and, at last year's hearing, agreed to comply with undertakings regarding his professional development. These included performing at least 70 hours of medical and surgical continuing professional development (CPD); providing the Disciplinary Committee Chairman with quarterly CPD reports and two employer reports regarding his competence; observing 24 days of current practice by shadowing another veterinary surgeon; and, providing reports from this veterinary surgeon as to his competence and a case diary.
The Committee considered the factual findings from the November 2010 hearing and the concerns then expressed about Mr MacMahon's conduct and capabilities as a veterinary surgeon, as well as his compliance with the agreed undertakings. As advised by the Legal Assessor, the Committee's considerations of sanction began at the lowest level that would ensure that the welfare of animals was properly protected; that proper standards would be maintained among practitioners in the profession; and, that would be in the interests of the public.
Speaking on behalf of the Disciplinary Committee, Chairman Professor Peter Lees said: "The Committee is satisfied that the respondent had complied fully with the spirit of the requirements of the undertakings he had entered into on 18 November 2010. Indeed, the view is that the respondent has done well to achieve the level of compliance that he has, given that he had suffered a period of significant ill-health during the period since he entered into those undertakings.
"The ultimate decision is that the respondent's conduct [...] warrants the imposition of at least a reprimand," he continued. "However, it is also the Committee's firm view that the respondent must be warned about his future conduct so that he will know the Committee considers he needs to maintain the level of continuous professional development that he has achieved [over the last] 12 months, and to have constantly in mind the paramount obligation of all veterinary surgeons to ensure the welfare of animals under their care.
"Such a warning as to future conduct should, and the Committee believes that it will, serve as a constant reminder to the respondent that he must undertake only those procedures, and only proffer professional advice, in the areas where he has the requisite up-to-date skills, knowledge and experience."
The Committee reprimanded Mr MacMahon and warned him as to his future conduct.
The company has won the Institute of Student Employers (ISE) 'Best Graduate Onboarding and Induction Activities Programme.' (Dear god. Not to take anything away from Vets4Pets' considerable achievement, but is it just me that finds it like fingernails on a blackboard when people take a perfectly serviceable preposition like 'on board' and turn it into a verb?).
Gordon Dunn, People Director at Vets4Pets, said: “As a leading UK veterinary employer, we view it as our personal responsibility to fully prepare graduates at the beginning of their career. This includes, but isn’t limited to, ensuring they are equipped with the right skills and behaviours to forge their own individual career pathway, and increase the chances of them remaining in the profession.
"The induction and onboarding of our graduates forms the lynchpin of our programme, and clearly sets out what is to come. Being recognised for the work we’re doing to develop the next generation of veterinary talent is a huge celebration for us and is a testimony to the investment made and hard work over the last few years to develop and evolve a world-class development programme. We’re extremely proud to be recognised for this achievement.”
Under the direction of Hilary Jackson and Rosanna Marsella, the manual has been revised and updated to provide a resource focused on the clinically relevant aspects of dermatological diseases. It also includes several new chapters and various sections have been expanded.
This new edition keeps the same format as the third edition. The initial chapters review the basic structure and function of the skin, discuss a logical approach to history-taking and outline the core investigative tests that can be performed. A separate chapter on skin cytology has been added to this edition, providing information on common skin diseases which the association says should be useful to all practitioners.
The introductory section is followed by chapters taking a problem-oriented approach to common dermatological conditions, including papules and pustules, scaling, and erosions and ulcerations. The chapters on pyoderma, ear disease and atopic dermatitis have been expanded and there are two new chapters dedicated to feline dermatological conditions.
A chapter covering the indications for allergy testing and the use of allergen-specific immunotherapy is also new to this edition. The main purpose of an allergy test is to confirm the clinical diagnosis of atopic disease and to identify the relevant allergens, which can then be selected for allergen-specific immunotherapy.
The final section of the manual focuses on the major skin diseases encountered in dogs and cats, and includes a chapter on topical treatments, which have an increasingly important role in the management of small animal dermatology patients, either as a sole therapy or as part of a multimodal treatment regime.
The BSAVA Manual of Canine and Feline Dermatology is available as a print edition (£90; £60 to BSAVA members), which can be bought at the BSAVA online shop, and a digital edition (£90; £60 to BSAVA members), accessible via the BSAVA Library.
The decision was made after Council heard increasing reports that practices have not been keeping records of POM-V parasiticide prescriptions within patient records as has always been required by the VMD.
This created a bit of a problem when the new 'under care' guidance came into force at the start of this month, which requires that veterinary surgeons must perform a physical examination as part of their initial clinical assessment of an animal before prescribing POM-V anti-parasitics.
Failing a record of an existing prescription, that would have meant re-examining large numbers of animals at a time when resources in the profession are already stretched.
RCVS President, Sue Paterson, said: “While it has been both surprising and disappointing to learn of such widespread non-compliance with legislation that has been in place for many years, Council decided to postpone the implementation of this one aspect of our new under care guidance to allow practices additional time to bring their prescribing protocols into line."
The delayed implementation date of 12 January 2024 relates only to the prescription of POM-V anti-parasitics.
The rest of the new under care guidance remains in effect from 1 September 2023
The RCVS said: "We understand that there are very strong opinions about the ban, and we respect the rights of individuals to make their own decisions.
"However, expressing these opinions can never justify or include the harassment and abuse of individual vets, vet nurses or their practice colleagues."
The BVA added: “The Government’s XL Bully ban is also placing additional pressure on veterinary teams who are doing their best in very challenging circumstances to help keep responsible XL Bully owners with their pets wherever possible.
"Their commitment extends to supporting clients with any decision-making around euthanasia in individual cases.
"It’s simply unacceptable for these professionals to face additional challenges through abuse, intimidation or threats.
"Such actions can have a hugely negative impact on individual vets and the wider team."
Resources:
Photo: Dlexus
Hill's Pet Nutrition is offering a series of free webinars about feline medicine, delivered by some of the best-known experts in the field.
The first presentation on feline liver disease will be delivered by Danièlle Gunn-Moore BVM&S BSc PhD MACVSc MRCVS, on the 26th January 2011. Martha Cannon BA VetMB DSAM(fel) MRCVS (pictured right) will present the next two webinars on Renal disease on 2nd March and Chronic Diarrhoea on 4th May. Both speakers are RCVS Specialists in feline medicine. Norman Johnston BVM&S, Dipl. AVDC, Dipl. EVDC, MRCVS, will be discussing stomatitis in the cat - a particularly problematic disease - on the 18th May. Norman is an RCVS, American and European Specialist in Veterinary Dentistry. The series will end on 8th June with Duncan Lascelles BSc, BVSc, PhD, CertVA, DSAS (ST), DECVS, DACVS, Associate Professor in Small Animal Surgery at North Carolina State, talking about osteoarthritis in the cat.
The events kick off at 8.30 pm and are hosted by the Webinar Vet (www.thewebinarvet.com). One initial registration provides access to the complete series, with scheduled e-mail reminders sent out prior to the latest webinar. To register, go to www.thewebinarvet.com/hills and enter your details as well as the code hillsnl.
Webinars are ideal for time pressed individuals who may not always be able to travel to a distant venue, yet still offer a 'real- time' and interactive experience. No special equipment is required, other than a reasonable standard PC or MAC and a broadband connection. The events are open to both vets and nurses but early registration is advisable to take full advantage of the whole Hill's Feline webinar series.
Merck and sanofi-aventis, owners of Merial and Intervet Schering-Plough respectively, have announced that they will not be combining the two animal health businesses as had been planned since March 2010.
In a joint announcement today, the companies said they are discontinuing their agreement primarily because of the increasing complexity of implementing the proposed transaction, both in terms of the nature and extent of the anticipated divestitures and the length of time necessary for the worldwide regulatory review process. The companies agreed that ending their plan is in the best interests of both companies and their respective shareholders, as well as the employees of Merial and Intervet/Schering Plough.
Sanofi-aventis says it remains strongly committed to its animal health activities, which it will continue to develop under the Merial brand as a growth platform of its diversified health business. Merial is one of the world's leading innovation-driven animal healthcare companies dedicated to research, development, manufacturing and commercialization of veterinary pharmaceuticals and vaccines, that generated annual sales of US $ 2.6 billion in 2010.
Merck has also stated its commitment to animal health and Intervet/Schering-Plough, a global leader in the research, development, manufacturing and sale of veterinary medicines which generated sales of US $ 2.9 billion in 2010
As a result of termination, both Merial and Intervet/Schering-Plough will continue to operate independently.
No word on the absolute number of 'concerns', but they included:
Jennie Jones, Head of VCMS and Partner at Nockolds Resolution (pictured right), said: "The COVID-19 pandemic and subsequent lockdown period has impacted many pet owners and veterinary practices. The increased use of remote consultations, and online and remote prescription services has been a great help to many during this time, but it also has its challenges as we all adapt to different ways of working. At the VCMS, we are well-equipped to take on complaints that eventuate in these circumstances, drawing on our past experience with prescription-related grievances and their resolution."
During 2018-19, the VCMS concluded 88% of complaints mediated using the ADR process developed by Nockolds.
Nockolds says it anticipates a rise in prescription-related complaints, and welcomes communication from practices and clients regarding these or any other vet-related complaints. Visit: http://www.nockolds.co.uk
As part of the scheme, Linnaeus offers one-to-one mentoring, professional and clinical skills development in primary care practices across the UK as part of the scheme.
The group, which now has more than 3,000 employees, delivers all clinical training in-house through its network of specialists, referral clinicians, certificate holders and primary care clinicians.
The 2021 programme applications will remain open until the end of May, unless all positions are filled sooner.
Chloe Roberts, clinical and educational development manager at Linnaeus, said: “This will be the fourth cohort to join our GDP and we’re looking forward to building on the successes we have enjoyed over the last three years.
“This has been a challenging year for obvious reasons, so it has been extremely heartening to see our new vets rise to that challenge and continue their professional journeys with our support.
“We’re excited to hear from the next intake of new vets and look forward to supporting them in their transition to clinical practice and recognise the additional challenges they faced joining the profession in the midst of a global pandemic.”
For more information, visit graduates.linnaeusgroup.co.uk or www.instagram.com/linnaeusgdp.
The new programme, which starts in May 2021, will address the fundamental principles underlying cardiac disease, discuss common presentations and review current diagnostic and therapeutic techniques.
Modules are delivered using a range of blended learning techniques, including interactive online lessons, supported by notes and videos.
While studying, delegates will have a module tutor – a recognised veterinary Specialist in their field - and a dedicated programme tutor, who works with individual delegates to support them through the programme.
Delegates can also choose three optional practical attendance sessions covering ECGs, thoracic radiography and echocardiography.
The programme offers a route through to achieving academic qualifications - General Practitioner Certificate (GPCert) and the Postgraduate Certificate (PgC), in partnership with the International School of Veterinary Postgraduate Studies (ISVPS) and Harper Adams University. Gaining a PgC enables delegates to apply to RCVS for Advanced Practitioner status in the subject.
Course Director Kieran Borgeat BSc BVSc MVetMed CertVC DipACVIM DipECVIM-CA MRCVS, said: "Improve International’s Cardiology DL programme features a diverse array of speakers from a variety of backgrounds, who will bring the latest information about veterinary cardiology to delegates. Our module leaders are world experts in their field so bring a thorough and uniquely engaging approach to the course material. Being able to discuss the topic with them and other course delegates online during each module of teaching during a two-year, in-depth course is a fantastic opportunity to connect with the topic as never before."
David Babington MRCVS, Business Development Director at Improve International, said: “Our cardiology programme has been designed to equip delegates with all of the skills and knowledge they need to confidently investigate, diagnose and treat cardiac patients.
“As we start to look ahead to a time beyond lockdowns, many veterinarians are taking stock and considering the next step in their career. For some, an additional qualification may be part of their plan. By offering a distance learning solution, we can ensure that, wherever in the world they are in practice, they have the opportunity to develop their clinical skills and achieve a postgraduate qualification.”
Registration information can be found here: https://www.improveinternational.com/uk/course/pgc-gpcert-small-animal-cardiology-distance-learning/
The poster gives information about things like lillies, chocolate, raisins, fertilisers, weedkillers and adders.
TVM will also be running its annual social media campaign about the most common spring dangers, giving practices digital content which they can share with clients.
To get a poster for your practice, contact your local TVM territory manager or visit https://www.tvm-uk.com/pet-dangers-order-free-display-materials-for-your-practice.
The series looks in detail at some of the most important issues dental specialists are seeing in pets.
The first webinar in the series, which is going live on Tuesday 3rd November at 8:00pm, looks at the impact periodontal disease has on both cats and dogs.
Co-speaker and veterinary dental specialist, Jens Ruhnau DVM, DEVDC (above, left) discusses the importance of understanding and treating the condition: "Research has shown that over 80% of dogs over the age of three, and the majority of cats, are impacted by periodontal disease. Treating the disease early and correctly is key to reducing further spread, secondary infection, and ultimately improving the quality of life of the animal".
The second webinar in the series, which will be live on Tuesday 10th November at 8:00pm, shares advice on treating tooth fractures in pets. Looking at tips on how to perform an effective oral examination, along with reviewing recent studies on the fracture limits of teeth in pet dogs.
Co-speaker and founder of DentalVets, Norman Johnston (above, right) said: "Tooth fractures are very common in both cats and dogs, and can be caused by a variety of reasons. Looking in more detail at the diagnostic process, treatments options and being aware of what objects can cause damage will help veterinary professionals, and in-turn owners, understand more about the risk of fractures."
Both webinars are free to attend, to find out more information and to register click here. https://www.thewebinarvet.com/pages/mars-petcare-free-webinars-tooth-fractures-periodontal-disease
On day one, Laura Playforth, IVC Evidensia’s Group Quality Improvement Director, will be looking at psychological safety and the adoption of a safety-critical culture in veterinary practice.
Sayaka Okushima from Pride Veterinary Referrals and Sarah Heath, IVC's Director of Sustainability, will be discussing the use of anaesthetic gases and ways to reduce them.
Other talks on day one will include: ‘Vets vs Nurses: Are we Blurring the Lines?’ and ‘The Criminal Underworld and Animal Welfare’.
On the second day, IVC referral clinicians will present lectures on various subjects, from handling emergency situations to mastering diagnostic testing equipment in first opinion practice.
David Owen, a Referral ECC Clinician at Vets Now in Manchester, will be talking about talking about emergency dyspnoea cases and how veterinary colleagues can cope with challenging situations efficiently.
Frances Bird, a European Specialist in Small Animal Surgery at Pride Veterinary Referrals, will be closing out the day with a discussion on treating respiratory disease from a surgeon’s perspective.
For the full programme, visit: https://london.vetshow.com/conference-programme?&filters.LOCATION=63903&searchgroup=ADD5CDE8-conference-programme-2023
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
An online presentation by Danielle Gunn-Moore, Professor of Feline Medicine at the Royal (Dick) School of Veterinary Studies in Edinburgh, has been launched by Dechra Veterinary Products as part of its Dechra Academy training suite.
During the presentation, Professor Gunn-Moore uses a case study approach to discuss all aspects of the condition from diagnosis through to its treatment, management and on-going monitoring. She reminds viewers that an individual approach must be taken in treating affected cats as the clinical signs can be subtle and starting treatment with the lowest possible dose of anti-thyroid medication is likely to prove physiologically beneficial.
"The study I've recently been involved in showed that the treatment of hyperthyroid cats can result in iatrogenic hypothyroidism*. Hypothyroid cats are significantly more likely to develop azotaemia than euthyroid cats - and hypothyroid cats that developed azotaemia in the study had significantly shorter survival times*.
"The message for practitioners is that there is no 'standard recipe' in treating hyperthyroidism. The clinical signs aren't always obvious and it's important to check for concurrent heart and kidney disease. You then need to tailor treatment, starting with a low dose of medication and, if necessary, increasing it by the smallest increments possible."
To watch Professor Gunn-Moore's presentation, visit www.dechra.co.uk/hyperthyroidism.
Reference:* Williams, T. et al (2010) JVIM 24: 1086-1092
The tracker, which Elanco produces with NADIS (National Animal Disease Information Service), highlights areas hit with blowfly strike in real-time, to provide a warning for farmers, veterinary surgeons and industry professionals.
The first reported incidents were in Hampshire, before spreading across Devon, West Sussex, and Buckinghamshire. Elanco says particularly severe cases include a flock in Dorset, in which 50% of a lamb group have been hit by blowfly strike. Latest reports are in northern England and some initial cases in Scotland.
The company says its blowfly risk forecast suggests that weather conditions from southern England and Wales to the Midlands mean that flies are now active, and females are laying eggs that could result in serious welfare and productivity issues.
Richard Wall, Professor of Zoology at Bristol University, said: "The timing and severity of blowfly strike is strongly influenced by the weather. This is a reminder to farmers that now is the time to act for early prevention. Delaying treatment not only costs the farm but risks the welfare and productivity of the flock."
Fiona Hutchings, Technical Vet at Elanco, said: "The costs of inaction when it comes to blowfly strike far outweigh the costs of protection. With 99% of farmers having suffered financial losses as a result of blowfly strike¹, the potential impact on your flock simply isn’t worth the risk. Farms need to take control — and take control early — by using a preventative IGR product with full fleece protection2."
Fiona added: "By the time symptoms show themselves, it’s often too late. It’s easy to overlook even one struck sheep, and blowfly strike can cause huge damage in very little time. In addition, using protection early reduces risk later in the season by ensuring a much lower fly count as the season progresses."
The workshop will be hosted by Renzo Di Florio (pictured right), veterinary advisor at Ceva Animal Health.
The session will look at the impact of Q Fever in the UK, outlining how it affects cattle health and reproductive performance and productivity.
It'll also cover identification of the disease and diagnosis, and prevention through vaccination and treatment.
For further information and to book tickets for TotalDairy, visit www.totaldairy.com (Ceva can offer a 10% discount on the purchase of tickets to the event using the code CEVA10).
At the heart of the new system is a transportable monitor (pictured right) which starts automatically after you connect two sensors and press the power button.
The system uses the handheld Darvall H100N Pulse Oximeter, which uses Nellcor OxiMax pulse oximetry technology.
It also comes with veterinary blood pressure NIBP small animal cuffs which are designed for accurate pressure detection in exotic animals, cats, and all sizes of dog.
Completing the Darvall Express system is the Darvall Capnograph which continuously measures the EtCO2 and respiratory rate, and features EtCO2 waveform Cardiac Oscillation artifact detection, for correct respiratory rate determination.
There's a default system set-up for cats and small dogs, a colour-coded display and a ten-hour battery life.
Darvall says the monitor has been thoroughly tested at veterinary practices in Australia, where it displayed outstanding performance in small dogs and cats, which are notoriously difficult to get reliable readings.
Darvall founder, Dr Colin Dunlop said: “Anaesthetic monitoring plays a vital role in keeping patients safe, giving peace of mind to the hospital veterinary team, and boosting pet owner confidence in the care their pet is receiving.
"This is vitally important when you remember mortality in veterinary patients is many times higher than in human hospital practice”.
http://www.aasmedical.co.uk
Part of the VN Futures project, the lunchtime webinars will be delivered between February and June 2020 via the Webinar Vet, and the College is encouraging all veterinary surgeons, nurses, practice managers and owners to attend, as it says the webinars will benefit the whole practice team.
All three webinars take place at 12.30pm and last one hour. They are as follows:
Tuesday 4 February 2020 – ‘Maximising the potential of the veterinary nurse’ presented by Louise Northway RVN, BVNA Council member and recipient of the RCVS Inspiration Award. The webinar will give an overview of the role of veterinary nurses under Schedule 3 of the Veterinary Surgeons Act, how VNs can develop their role in practice and take on extra responsibilities and how VNs can approach these conversations in practice through the creation of learning and development plans. This webinar will illustrate how fully utilising the nursing team not only hugely boosts the morale of the work force, but also enhances patient care and increases the efficiency of the business.
Tuesday 10 March 2020 – ‘Veterinary nurses’ time is valuable: How and why to charge for it’ presented by Stephanie Writer-Davies MRCVS, Career Progression Working Group member, and Jane Davidson RVN, VN Council member and regular blogger on veterinary nursing issues. This webinar will provide examples and case studies of how veterinary nurses contribute to practice finances, how practice pricing structures can be developed so that the financial value of veterinary nurses’ time and effort can be better highlighted, and how veterinary nurses can demonstrate their value to clients.
Tuesday 23 June 2020 – ‘Lead or Head RVN: What’s in a name?’ presented by Gillian Page RVN, President of the Veterinary Management Group. This webinar will look at the role of the traditional Head RVN and how development of ‘Lead RVNs’ in different areas of practice can help to allow for growth of other talented team members and provide increased and shared responsibility and progression. This webinar will explore how this enhances practice efficiency alongside development of team members, thus increasing job satisfaction and, ultimately, retention.
Racheal Marshall, Chair of RCVS Veterinary Nurses Council and the VN Futures Board, said: "We hope that veterinary nurses will engage with these webinars in order to gain some inspiration about how they can truly show their value to their team, their clients and the wider public.
"The VN Futures research clearly demonstrated that there was a desire from the veterinary nursing profession to find ways in which VNs could gain greater recognition for the work they do and progress in their careers. These webinars, and our talented presenters, will provide many practical examples and case studies on how this can be done, help build confidence and highlight opportunities for further learning and development."
To sign up to the free webinars, visit: https://www.thewebinarvet.com/sponsors/VN%20Futures.
Two hundred members of the profession took part. The main results were:
For this study, researchers in Argentina, Italy, Austria and Chile, set out to evaluate the efficacy of and adverse events from the administration of ACEIs to treat preclinical MMVD in dogs, via a systematic review of published evidence conducted according to the Cochrane Handbook for Systematic Reviews of Interventions.
Certainty of evidence was assessed using the GRADE (https://gradepro.org) approach.
The main finding in relation to dogs with preclinical MMVD and cardiomegaly was backed by a high certainty of evidence. The certainty of evidence in relation to the efficacy of ACEI administration in dogs without cardiomegaly was low.
Dr Pablo Donati, corresponding author for the paper, said: “In recent times, multiple clinical trials have provided fundamental information to veterinary cardiology.
"In the era of evidence-based medicine, systematic reviews and meta-analyses have emerged as a fundamental tool for clinical decision-making by gathering, appraising and summarizing the best available evidence.
"It is the hope of the authors that this systematic review and meta-analysis helps in the decision-making process for the treatment of preclinical myxomatous mitral disease with angiotensin-converting enzyme inhibitors in dogs.”
Nicola Di Girolamo, Editor of JSAP, added: “In line with other leading journals, the JSAP is prioritizing the publication of methodologically sound systematic reviews such as this one.
"However, our readers should be aware that the findings of systematic reviews should always be considered in light of their internal validity, i.e. the quality of the included studies, and their external validity, i.e. the generalizability of the included studied to the individual patient.”
Reference
Donati, P., Tarducci, A., Zanatta, R., Verdier, N., Belerenian, G., Cordero, I., Villalta, C., Franco, J. and Tarragona, L. (2022), Angiotensin-converting enzyme inhibitors in preclinical myxomatous mitral valve disease in dogs: systematic review and meta-analysis. J Small Anim Pract. https://doi.org/10.1111/jsap.13461